Sodium-Glucose Cotransporter-2 Inhibitors in Nephrology Practice: A Narrative Review
Volume: 7, Pages: 205435812093570 - 205435812093570
Published: Jan 1, 2020
Abstract
Purpose of the review: Sodium-glucose cotransporter-2 inhibitors (SGLT2is) are recommended for eligible patients with type 2 diabetes for the secondary prevention of adverse cardiovascular and kidney disease outcomes. Patients with type 2 diabetes and albuminuric chronic kidney disease, a history of atherosclerotic cardiovascular disease, and/or heart failure with reduced ejection fraction should be assessed for the use of these therapies....
Paper Details
Title
Sodium-Glucose Cotransporter-2 Inhibitors in Nephrology Practice: A Narrative Review
Published Date
Jan 1, 2020
Volume
7
Pages
205435812093570 - 205435812093570
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History